Federal Register / Vol. 74, No. 24 / Friday, February 6, 2009 / Notices 6309 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Overview of This Information 

Collection 

(1) Type of Information Collection: 

Proposed collection; comments 

requested. 

(2) Title of the Form/Collection: 

Community Policing Self-Assessment 

(CP–SAT). 

(3) Agency form number, if any, and 

the applicable component of the 

Department sponsoring the collection: 

None. U.S. Department of Justice Office 

of Community Oriented Policing 

Services. 

(4) Affected public who will be asked 

or required to respond, as well as a brief 

abstract: Primary: Law Enforcement 

Agencies and community partners. The 

purpose of this project is to improve the 

practice of community policing 

throughout the United States by 

supporting the development of a series 

of tools that will allow law enforcement 

agencies to gain better insight into the 

depth and breadth of their community 

policing activities. 

(5) An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond/reply: It is estimated that 

approximately 800 respondents will 

respond with an average of 1 hour per 

response. 

(6) An estimate of the total public 

burden (in hours) associated with the 

collection: The total estimated burden is 

800 hours across 103 agencies. 

If additional information is required 

contact: Lynn Bryant, Department 

Clearance Officer, United States 

Department of Justice, Justice 

Management Division, Policy and 

Planning Staff, Patrick Henry Building, 

Suite 1600, 601 D Street, NW., 

Washington, DC 20530. 

Dated: February 3, 2009. 

Lynn Bryant, 

Department Clearance Officer, PRA, United 

States Department of Justice. 

[FR Doc. E9–2585 Filed 2–5–09; 8:45 am] 

BILLING CODE 4410–AT–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Application 

Pursuant to Title 21 Code of Federal 

Regulations 1301.34(a), this is notice 

that on December 19, 2008, 

Mallinckrodt Inc., 3600 North Second 

Street, St. Louis, Missouri 63147, made 

application by renewal to the Drug 

Enforcement Administration (DEA) for 

registration as an importer of the basic 

classes of controlled substances listed in 

schedule II: 

Drug Schedule 

Phenylacetone (8501) .................. II 

Coca Leaves (9040) ..................... II 

Opium, raw (9600) ....................... II 

Poppy Straw (9650) ..................... II 

Poppy Straw Concentrate (9670) II 

The company plans to import the 

listed controlled substances for the 

manufacture of controlled substances in 

bulk for distribution to its customers. 

No comments, objections, or requests 

for any hearings will be accepted on any 

application for registration or reregistration to import crude opium, 

poppy straw, concentrate of poppy 

straw or coca leaves. As explained in 

the Correction to Notice of Application 

pertaining to Rhodes Technologies, 72 

FR 3417 (2007), comments and requests 

for hearings on applications to import 

narcotic raw material are not 

appropriate. 

Any bulk manufacturer who is 

presently, or is applying to be, 

registered with DEA to manufacture 

such basic classes of controlled 

substances listed in schedule I or II, 

which fall under the authority of section 

1002(a)(2)(B) of the Act (21 U.S.C. 

952(a)(2)(B)) may, in the circumstances 

set forth in 21 U.S.C. 958(i), file 

comments or objections to the issuance 

of the proposed registration and may, at 

the same time, file a written request for 

a hearing on such application pursuant 

to 21 CFR 1301.43 and in such form as 

prescribed by 21 CFR 1316.47. 

Any such comments or objections 

should be addressed, in quintuplicate, 

to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, VA 22152; and must be 

filed no later than March 9, 2009. 

This procedure is to be conducted 

simultaneously with and independent 

of the procedures described in 21 CFR 

1301.34(b), (c), (d), (e), and (f). As noted 

in a previous notice published in the 

Federal Register on September 23, 1975, 

(40 FR 43745), all applicants for 

registration to import a basic class of 

any controlled substances in schedule I 

or II are, and will continue to be, 

required to demonstrate to the Deputy 

Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration, that the requirements 

for such registration pursuant to 21 

U.S.C. 958(a); 21 U.S.C. 823(a); and 21 

CFR 1301.34(b), (c), (d), (e), and (f) are 

satisfied. 

Dated: January 30, 2009. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E9–2543 Filed 2–5–09; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated October 9, 2008 and 

published in the Federal Register on 

October 17, 2008 (73 FR 61909), 

Cerilliant Corporation, 811 Paloma 

Drive, Suite A, Round Rock, Texas 

78665–2402, made application by 

renewal to the Drug Enforcement 

Administration (DEA) to be registered as 

a bulk manufacturer of the basic classes 

of controlled substances listed in 

schedules I and II: 

Drug Schedule 

Cathinone (1235) ......................................................................................................................................................................................... I 

Methcathinone (1237) .................................................................................................................................................................................. I 

N-Ethylamphetamine (1475) ........................................................................................................................................................................ I 

N,N-Dimethylamphetamine (1480) .............................................................................................................................................................. I 

Aminorex (1585) .......................................................................................................................................................................................... I 

4-Methylaminorex (cis isomer) (1590) ......................................................................................................................................................... I 

Gamma-Hydroxybutyric acid (2010) ............................................................................................................................................................ I 

Methaqualone (2565) .................................................................................................................................................................................. I 

Alpha-ethyltryptamine (7249) ...................................................................................................................................................................... I 


dwashington3 on PROD1PC60 with NOTICES
6310 Federal Register / Vol. 74, No. 24 / Friday, February 6, 2009 / Notices 

Drug Schedule 

Lysergic acid diethylamide (7315) ............................................................................................................................................................... I 

Marihuana (7360) ........................................................................................................................................................................................ I 

Tetrahydrocannabinols (7370) ..................................................................................................................................................................... I 

Mescaline (7381) ......................................................................................................................................................................................... I 

3,4,5-Trimethoxyamphetamine (7390) ........................................................................................................................................................ I 

4-Bromo-2,5-dimethoxyamphetamine (7391) .............................................................................................................................................. I 

4-Bromo-2,5-dimethoxyphenethylamine (7392) .......................................................................................................................................... I 

4-Methyl-2,5-dimethoxyamphetamine (7395) .............................................................................................................................................. I 

2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................ I 

2,5-Dimethoxy-4-ethylamphetamine (7399) ................................................................................................................................................ I 

3,4-Methylenedioxyamphetamine (7400) .................................................................................................................................................... I 

5-Methoxy-3,4-methylenedioxyamphetamine (7401) .................................................................................................................................. I 

N-Hydroxy-3,4-methylendioxyamphetamine (7402) .................................................................................................................................... I 

3,4-Methylendioxy-N-ethylamphetamine (7404) .......................................................................................................................................... I 

3,4-Methylenedioxymethamphetamine (7405) ............................................................................................................................................ I 

4-Methoxyamphetamine (7411) ................................................................................................................................................................... I 

Alpha-methyltryptamine (7432) ................................................................................................................................................................... I 

Bufotenine (7433) ........................................................................................................................................................................................ I 

Diethyltryptamine (7434) ............................................................................................................................................................................. I 

Dimethyltryptamine (7435) .......................................................................................................................................................................... I 

Psilocybin (7437) ......................................................................................................................................................................................... I 

Psilocyn (7438) ............................................................................................................................................................................................ I 

N-Benzylpiperazine (7493) .......................................................................................................................................................................... I 

Acetyldihydrocodeine (9051) ....................................................................................................................................................................... I 

Benzylmorphine (9052) ............................................................................................................................................................................... I 

Codeine-N-oxide (9053) .............................................................................................................................................................................. I 

Dihydromorphine (9145) .............................................................................................................................................................................. I 

Heroin (9200) ............................................................................................................................................................................................... I 

Hydromorphinol (9301) ................................................................................................................................................................................ I 

Methyldihydromorphine (9304) .................................................................................................................................................................... I 

Morphine-N-oxide (9307) ............................................................................................................................................................................. I 

Normorphine (9313) .................................................................................................................................................................................... I 

Pholcodine (9314) ....................................................................................................................................................................................... I 

Acetylmethadol (9601) ................................................................................................................................................................................. I 

Allylprodine (9602) ....................................................................................................................................................................................... I 

Alphacetylmethadol except levo-alphacetylmethadol (9603) ...................................................................................................................... I 

Alphameprodine (9604) ............................................................................................................................................................................... I 

Alphamethadol (9605) ................................................................................................................................................................................. I 

Betacetylmethadol (9607) ............................................................................................................................................................................ I 

Betameprodine (9608) ................................................................................................................................................................................. I 

Betamethadol (9609) ................................................................................................................................................................................... I 

Betaprodine (9611) ...................................................................................................................................................................................... I 

Hydroxypethidine (9627) ............................................................................................................................................................................. I 

Noracymethadol (9633) ............................................................................................................................................................................... I 

Norlevorphanol (9634) ................................................................................................................................................................................. I 

Normethadone (9635) ................................................................................................................................................................................. I 

Trimeperidine (9646) ................................................................................................................................................................................... I 

Phenomorphan (9647) ................................................................................................................................................................................. I 

Para-Fluorofentanyl (9812) .......................................................................................................................................................................... I 

3-Methylfentanyl (9813) ............................................................................................................................................................................... I 

Alpha-Methylfentanyl (9814) ........................................................................................................................................................................ I 

Acetyl-alpha-methylfentanyl (9815) ............................................................................................................................................................. I 

Beta-hydroxyfentanyl (9830) ....................................................................................................................................................................... I 

Beta-hydroxy-3-methylfentanyl (9831) ........................................................................................................................................................ I 

Alpha-Methylthiofentanyl (9832) .................................................................................................................................................................. I 

3-Methylthiofentanyl (9833) ......................................................................................................................................................................... I 

Thiofentanyl (9835) ...................................................................................................................................................................................... I 

Amphetamine (1100) ................................................................................................................................................................................... II 

Methamphetamine (1105) ........................................................................................................................................................................... II 

Phenmetrazine (1631) ................................................................................................................................................................................. II 

Methylphenidate (1724) ............................................................................................................................................................................... II 

Amobarbital (2125) ...................................................................................................................................................................................... II 

Pentobarbital (2270) .................................................................................................................................................................................... II 

Secobarbital (2315) ..................................................................................................................................................................................... II 

Glutethimide (2550) ..................................................................................................................................................................................... II 

Nabilone (7379) ........................................................................................................................................................................................... II 

1-Phenylcyclohexylamine (7460) ................................................................................................................................................................. II 

Phencyclidine (7471) ................................................................................................................................................................................... II 

1-Piperidinocyclohexanecarbonitrile (8603) ................................................................................................................................................ II 

Alphaprodine (9010) .................................................................................................................................................................................... II 

Cocaine (9041) ............................................................................................................................................................................................ II 

Codeine (9050) ............................................................................................................................................................................................ II 

Dihydrocodeine (9120) ................................................................................................................................................................................ II 

Oxycodone (9143) ....................................................................................................................................................................................... II 


dwashington3 on PROD1PC60 with NOTICES
Federal Register / Vol. 74, No. 24 / Friday, February 6, 2009 / Notices 6311 

Drug Schedule 

Hydromorphone (9150) ............................................................................................................................................................................... II 

Diphenoxylate (9170) .................................................................................................................................................................................. II 

Benzoylecgonine (9180) .............................................................................................................................................................................. II 

Ethylmorphine (9190) .................................................................................................................................................................................. II 

Hydrocodone (9193) .................................................................................................................................................................................... II 

Levomethorphan (9210) .............................................................................................................................................................................. II 

Levorphanol (9220) ..................................................................................................................................................................................... II 

Isomethadone (9226) .................................................................................................................................................................................. II 

Meperidine (9230) ....................................................................................................................................................................................... II 

Meperidine intermediate-A (9232) ............................................................................................................................................................... II 

Meperidine intermediate-B (9233) ............................................................................................................................................................... II 

Meperidine intermediate-C (9234) ............................................................................................................................................................... II 

Methadone (9250) ....................................................................................................................................................................................... II 

Methadone intermediate (9254) .................................................................................................................................................................. II 

Dextropropoxyphene, bulk (non-dosage forms) (9273) .............................................................................................................................. II 

Morphine (9300) .......................................................................................................................................................................................... II 

Thebaine (9333) .......................................................................................................................................................................................... II 

Levo-alphacetylmethadol (9648) ................................................................................................................................................................. II 

Oxymorphone (9652) ................................................................................................................................................................................... II 

Noroxymorphone (9668) .............................................................................................................................................................................. II 

Racemethorphan (9732) .............................................................................................................................................................................. II 

Alfentanil (9737) .......................................................................................................................................................................................... II 

Sufentanil (9740) ......................................................................................................................................................................................... II 

Fentanyl (9801) ........................................................................................................................................................................................... II 

The company plans to manufacture 

small quantities of the listed controlled 

substances to make reference standards 

which will be distributed to their 

customers. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Cerilliant Corporation to manufacture 

the listed basic classes of controlled 

substances is consistent with the public 

interest at this time. DEA has 

investigated Cerilliant Corporation to 

ensure that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823, 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: January 30, 2009. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E9–2541 Filed 2–5–09; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated October 7, 2008 and 

published in the Federal Register on 

October 14, 2008, (73 FR 60719), Halo 

Pharmaceutical Inc., 30 North Jefferson 

Road, Whippany, New Jersey 07981, 

made application to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

the basic classes of controlled 

substances listed in schedules I and II: 

Drug Schedule 

Dihydromorphine (9145) ............... I 

Hydromorphone (9150) ................ II 

Dihydromorphine is an intermediate 

in the manufacture of Hydromorphone 

and is not for commercial distribution. 

The company plans to manufacture 

Hydromorphone HCL for sale to other 

manufacturers and for the manufacture 

of other controlled substance dosage 

units for distribution to its customers. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of Halo 

Pharmaceutical Inc. to manufacture the 

listed basic classes of controlled 

substances is consistent with the public 

interest at this time. DEA has 

investigated Halo Pharmaceutical Inc. to 

ensure that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823, 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: January 30, 2009. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E9–2538 Filed 2–5–09; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF LABOR 

Employment and Training 

Administration 

Employment and Training 

Administration Notice of 

Implementation of Supplemental 

Appropriations Act, 2008, Title IV— 

Emergency Unemployment 

Compensation, and the Unemployment 

Compensation Extension Act 

AGENCY: Employment and Training 

Administration, Labor. 

ACTION: Notice. 

SUMMARY: The Employment and 

Training Administration (ETA) of the 

United States Department of Labor (the 

Department) is publishing, for public 

information, notice of the issuance and 

availability of the Unemployment 

Insurance Program Letters (UIPL) that 


dwashington3 on PROD1PC60 with NOTICES